DIAMOND-2: A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2) (clinicaltrials.gov) - May 2, 2026 - P3 | N=401 | Completed | Sponsor: Oculis | Active, not recruiting ➔ Completed
Trial completion • Diabetic Macular Edema • Ophthalmology
|